The best advice I can give to this message board is for
The best advice I can give to this message board is for people to try to think objectively about what they're hearing. Consider whether JBI's problems are 100% related to FUD as you're being told by many here or whether at least some of the blame should go to JBI itself for some self-inflicted problems.
The best step a person could take is to e-mail JBI and ask whether there's any evidence that what comes out of the processor is worth more than the feedstock going in. A person could also ask what's holding up that profitable operation of processors #2 and #3. Processor #2 was supposedly fully operating in February 2012. Processor #3 has been good to go except for a slow startup for about a year.
I understand that many don't want to ask IR those questions for various reasons. Although it's not as fast, an alternative would be to draw a line in the sand. On August 15th, it will have been a year since the focus on processor sales started. If there's not any evidence of a *completed* sale by that time, it might be good to cut bait. Pick any time line where you feel comfortable.
Keep in mind that Mr. Bordynuik can change business plans and keep things fresh for virtually forever, until investors decide to stop funding him. Investors are never given any excuse why the previous business plans are abandoned but always pin their hopes on the new, fresh business plan put out by Mr. Bordynuik. So far none of the changes in business plans have ever panned out. With a highly profitable process such as what Mr. Bordynuik claims to have, virtually any business plan should work. They never do.
Barring any of the above advice, at least follow the adage of not putting more money in JBII than you can afford to lose.
Plastic2Oil, Inc. (PTOI) Stock Research Links
Yes, I understand your penny stock also is the real deal, created with the inventiveness of Edison and destined to be the next Microsoft. Yes, I understand that the delays are also only because your company is making their product and/or technology even more revolutionary.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Chicago's Diwali Tribute: Music, Dance, and Diversity Talk about spreading the glow! On November 13, 2026, Cook County Treasurer Maria Pappas is gearing up to throw a Diwali bash that'll light up Chicago's cultural landscape. Alongside Indian Consul General Dr. M. Anand Prakash, she's orchestrating a vibrant affair designed to spotlight Indian American community leaders...
Continue Reading
AI in Banking: Cautious Steps Forward Banks aren't exactly racing with AI; they're inching forward. With AI agents entering the picture, you'd think the buzz would be about groundbreaking deployments. Instead, the story here is more about banks holding their cards close to the vest. Agentic AI, with its ability to plan and act without a human babysitter at every step, is...
Continue Reading
Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...
Continue Reading
A Global Push for Clean Energy: POWERCHINA's Role Picture this: a bustling global scene at the United Nations Climate Change Conference, COP31, in Antalya, with leaders huddling over the future of our planet's energy. Meanwhile, Power Construction Corporation of China (POWERCHINA) is out there in the trenches, muscling through the monumental task of turning ambitious...
Continue Reading
Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...
Continue Reading
The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...
Continue Reading
Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...
Continue Reading
NueSynergy Earns its Stripes in 2026 It seems these days, healthcare costs are rising faster than you can say 'deductible.' In this chaotic landscape, a good HSA provider is worth its weight in gold. Enter NueSynergy, whose efforts have once again been acknowledged by Morningstar, a big name in the world of investment research. What Sets NueSynergy Apart? NueSynergy isn't...
Continue Reading
The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...
Continue Reading
Navigating the Waters of Seafood Quality When it comes to throwing together a proper Louisiana seafood boil, your whole evening could sink or swim based on seafood freshness. Jonathan Sumich, a grocery veteran from Oak Point Fresh Market, spills the beans on picking the cream of the crop. Plan it right, and you’re the hero of the feast. Ignore these tips, and you might...
Continue Reading
Top 5 Most Recently Viewed Articles
Investigating the Class Action Lawsuit Against Elevance Health Investors should be aware of the ongoing class action lawsuit involving Elevance Health, Inc. (NYSE: ELV). This lawsuit has been initiated to address significant concerns regarding false and misleading statements made by the company. The deadline for potential lead plaintiffs to participate is approaching, and...
Continue Reading
Introduction to Unified Imaging Services In a groundbreaking development, Sweden's Region Stockholm is set to transform its medical imaging landscape. By utilizing the innovative enterprise imaging solution provided by Sectra, a leader in medical imaging IT, all hospitals within the region will transition to a holistic cloud service. This monumental shift aims to enhance...
Continue Reading
G2 Goldfields Expands Mineral Resources at OKO G2 Goldfields Inc. (“G2”) (TSX: GTWO; OTCQX: GUYGF) has some exciting updates to share about its exploration activities at the vast 27,719-acre OKO-AREMU gold project. The company recently provided a significant update on their Mineral Resource Estimate (MRE), which now shows a remarkable total of 922,000 ounces of gold...
Continue Reading
Charles River Laboratories Faces Downgrade from Citi Charles River Laboratories International Inc. (NYSE: CRL), recognized for its pivotal role in preclinical and clinical laboratory services, has recently encountered a downgrade in its stock rating from the prominent firm Citi. This adjustment is a significant indicator of the shifting dynamics in the pharmaceutical...
Continue Reading
Banco Comercial Português, S.A. Reports Its 2024 Earnings Banco Comercial Português, S.A., one of the major banking institutions, has unveiled its consolidated earnings for the year 2024. The financial results highlight a strong performance, indicating the bank's resilience and adaptability in a competitive marketplace. Overview of Earnings The bank exhibited robust...
Continue Reading